MetaCap

Ginkgo Bioworks Statistics

NYSE: DNAHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

7.46-0.74 (-9.02%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Ginkgo Bioworks by the numbers

Ginkgo Bioworks has a market capitalization of $483.5 million based on 53.94M shares outstanding. With trailing EPS of $-4.24, Ginkgo Bioworks is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 28.4% below its 50-day average and 13.5% below its 200-day average.

Average daily trading volume is 2.53M shares, or about $18.9 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

DNA valuation vs. peer median

DNA compared with the median of 8 peer companies
MetricDNAPeer medianDifference
Market cap$483.54M$467.79M+3%
Avg. volume2.53M390.07K+548%

Peer median across 8 companies: SANA, VALN, RGNX, FENC, ETRA, IRLA, PROK, TECX.

Valuation

Market cap
$483.54M
Price / sales (latest FY)
2.84
EPS (TTM)
$-4.24

Price and trading

Previous close
8.20
Open
7.93
Day range
7.39 – 8.28
52-week range
5.37 – 18.22
52-week change
-8.69%
Beta
—
Volume
2.50M

Dividends and events

Annual dividend
None

Additional statistics

Market Cap
483.54M
Forward Pe
-2.57
Eps
-4.24
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
18.22
Week52 Low
5.37
Avg Volume
2.53M
Shares Outstanding
53.94M
Ma50
10.42
Ma200
8.63
Earnings Date
Nov 5, 2026
Pct From52w High
-59.06%
Pct From52w Low
38.92%

Related